What it is (overview)

An abdomen biopsy with imaging guidance is a minimally invasive procedure where a clinician removes a small tissue sample from an organ or mass inside the belly (abdomen) to look at it under a microscope. Because many abdominal structures are deep and close to important blood vessels and organs, the biopsy is performed using imaging guidance—most commonly ultrasound or a CT scan—to precisely target the area of concern. This helps improve accuracy and reduces the risk of complications.

The biopsy does not “measure” a single number like a blood test. Instead, a pathologist examines the tissue for changes such as inflammation, infection, abnormal cell growth, scarring, or tumors (benign or cancerous). In some cases, additional testing is done on the sample (for example, special stains, cultures, or molecular tests) to identify a specific infection or tumor type.

In plain language, your results may mean:

• Benign (non-cancerous) findings: The tissue looks non-cancerous, such as cysts, fatty changes, or non-malignant growths.
• Inflammation or autoimmune-related changes: Suggests inflammatory disease or organ irritation that may respond to medication.
• Infection: The sample shows organisms or changes consistent with infection (sometimes requiring antibiotics or antifungal treatment).
• Pre-cancer or cancer: Abnormal cells consistent with a tumor; the report often includes the tumor type and may guide staging and treatment planning.
• Non-diagnostic/insufficient sample: Not enough tissue or the target area was missed; a repeat biopsy or different test may be recommended.

Depending on the target, this test may be described more specifically, such as a liver biopsy, kidney biopsy, pancreas biopsy, or biopsy of an abdominal lymph node or mass.

When & why it's usually done

Doctors typically order an abdomen biopsy with ultrasound or CT guidance when imaging or symptoms suggest there is an abnormal area that needs a definite diagnosis. While scans can show the size, shape, and location of a lesion, a biopsy can confirm what it is by examining actual cells and tissue structure.

It’s commonly recommended when a person has:

• An abnormal finding on imaging: a mass, nodule, enlarged lymph node, or unexplained lesion seen on ultrasound, CT, or MRI.
• Concern for tumors: to confirm whether a growth is benign or cancerous and to identify the exact tumor type.
• Unexplained abdominal symptoms that persist and need clarification, such as ongoing abdominal pain, bloating, early fullness, or unexplained nausea.
• Unexplained weight loss, fever, or night sweats when cancer or chronic infection is considered.
• Abnormal liver tests or suspected liver disease, especially when the cause is unclear or when tissue confirmation will change treatment.
• Kidney problems where a tissue diagnosis can guide therapy (for example, certain inflammatory or immune-related kidney diseases).
• Suspected infection or abscess in the abdomen that may require targeted therapy based on lab analysis of the sample.
• Follow-up of known cancer to confirm spread (metastasis), assess recurrence, or obtain tissue for updated tumor testing.

The main reasons for choosing imaging guidance are accuracy and safety. Ultrasound guidance is often used because it can provide real-time imaging without radiation, while a CT-guided biopsy may be preferred for deeper lesions or when ultrasound visibility is limited (for example, due to bowel gas or body habitus).

Common diseases related to it

• Primary liver cancer (hepatocellular carcinoma)
• Metastatic cancer to the liver or other abdominal organs
• Pancreatic cancer and pancreatic neuroendocrine tumors
• Kidney cancer (renal cell carcinoma)
• Lymphoma involving abdominal lymph nodes
• Benign liver lesions (such as hemangioma, focal nodular hyperplasia, hepatic adenoma—biopsy may be used selectively)
• Hepatitis (including autoimmune hepatitis) and chronic liver inflammation
• Liver fibrosis/cirrhosis evaluation (in selected cases)
• Granulomatous diseases (such as sarcoidosis or tuberculosis affecting abdominal organs)
• Abdominal infections or abscesses requiring organism identification
• Inflammatory conditions of abdominal organs (organ-specific inflammatory disease)

Health goals where it may help

• Getting a definitive diagnosis for an abdominal mass seen on ultrasound or CT scan
• Clarifying whether a suspected tumor is benign or malignant to guide next steps
• Planning the most appropriate treatment (surgery, chemotherapy, immunotherapy, antibiotics, or targeted therapy) based on tissue findings
• Monitoring and managing liver health (confirming the cause of abnormal liver tests or suspected chronic liver disease)
• Evaluating kidney disease when a tissue diagnosis will change treatment choices
• Confirming cancer spread (staging) or recurrence to support accurate care planning
• Identifying the cause of unexplained inflammation or infection in the abdomen for more targeted therapy
• Supporting personalized medicine by obtaining tissue for specialized tumor testing when needed